Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5117]
News [14821]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
ZUMA1 trial of CD19 CAR T cells for aggressive NHL
Dr Yi Lin - Mayo Clinic, Rochester, USA
ZUMA1 trial of CD19 CAR T cells for aggressive NHL ( Dr Yi Lin - Mayo Clinic, Rochester, USA )
24 Jun 2017
400mg imatinib as good as 800mg for 10 year CML survival
Prof Rüdiger Hehlmann - European LeukemiaNet, Mannheim, Germany
400mg imatinib as good as 800mg for 10 year CML survival ( Prof Rüdiger Hehlmann - European LeukemiaNet, Mannheim, Germany )
23 Jun 2017
Carfilzomib combinations in ENDEAVOR and FORTE
Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Carfilzomib combinations in ENDEAVOR and FORTE ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
23 Jun 2017
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Diverse T lymphocyte population fights leukaemia more effectively
Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany
Diverse T lymphocyte population fights leukaemia more effectively ( Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany )
23 Jun 2017
Delayed exposure to common infections causes acute childhood leukaemia
Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical...
Delayed exposure to common infections causes acute childhood leukaemia ( Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical Immunology, Düsseldorf, Germany )
23 Jun 2017
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed...
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Improving outcomes for oestrogen receptor positive breast cancer
Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy
Improving outcomes for oestrogen receptor positive breast cancer ( Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy )
19 Jun 2017
European guidelines for breast cancer treatment
Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium
European guidelines for breast cancer treatment ( Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium )
19 Jun 2017
The European Alliance for Personalised Medicine
Denis Horgan - European Alliance for Personalised Medicine, Belgium
The European Alliance for Personalised Medicine ( Denis Horgan - European Alliance for Personalised Medicine, Belgium )
19 Jun 2017
Europa Uomo - improving prostate cancer patients quality of life across Europe
Prof Louis Denis - Europa Uomo, Belgium
Europa Uomo - improving prostate cancer patients quality of life across Europe ( Prof Louis Denis - Europa Uomo, Belgium )
19 Jun 2017
Personalised medicine for rare cancers
Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy
Personalised medicine for rare cancers ( Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy )
19 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation